— Know what they know.
Not Investment Advice

CBST NASDAQ

Cubist Pharmaceuticals Inc.
1W: +1.0% 1M: +4.3% 3M: +51.4% 1Y: +35.9% 3Y: +148.5% 5Y: +402.2%
$101.94
Last traded 2015-01-21 — delisted
NASDAQ · Healthcare · Biotechnology
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range101.99-58.5
Volume8,021,159
Avg Volume1,222,237
Beta0.70
Dividend—
Analyst Ratings
No analyst coverage
Company Info
Employees873
SectorHealthcare
IndustryBiotechnology
IPO Date1996-10-25
Websitecubist.com
65 Hayden Avenue
Lexington 02421
US
1-781-860-8660
About Cubist Pharmaceuticals Inc.

Cubist Pharmaceuticals LLC operates as a pharmaceutical enterprise, concentrating its efforts on the research, development, and market introduction of medical treatments. These treatments are specifically designed to meet substantial, unfulfilled patient needs within critical care environments.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
MOULDER LEON O JR D-Return 1,687 — 2015-01-21
Lawton Alison France D-Return 1,687 — 2015-01-21
Hutson Nancy J D-Return 1,687 — 2015-01-21
HENNEY JANE E MD D-Return 1,687 — 2015-01-21
CORRIGAN MARK D-Return 1,687 — 2015-01-21

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms